The original success of Viagra undeniably transformed the medication landscape, but investing in companies primarily reliant on off-patent versions presents a complex picture. Despite early returns were impressive, the end of patents and the rise of cheaper alternatives have diminished the customer base. Therefore, a thorough analysis of current in